Fresenius Medical Care AG & Co. (ADR) (FMS) reported quarterly earnings results on Tuesday, May-3-2016. The company reported $0.75 EPS for the quarter. Analysts had a consensus estimate of $0.75. The company posted revenue of $4205.00 million in the period, compared to analysts expectations of $4223.64 million. The company’s revenue was up 6.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.69 EPS.
Fresenius Medical Care AG & Co. (ADR) opened for trading at $43.96 and hit $44.19 on the upside on Monday, eventually ending the session at $44.19, with a gain of 1.28% or 0.56 points. The heightened volatility saw the trading volume jump to 85,703 shares. Company has a market cap of $26,984 M.
Fresenius Medical Care AG & Co. KGaA (FMC AG & CO. KGAA) is a kidney dialysis company. The Company provides dialysis care services related to the dialysis treatment a patient receives with end-stage renal disease (ESRD) as well as other health care services. FMC AG & CO. KGAA also provides dialysis products for the treatment of ESRD which includes manufacturing and distributing products such as hemodialysis machines peritoneal cyclers dialyzers peritoneal solutions hemodialysis concentrates solutions and granulates bloodlines renal pharmaceuticals and systems for water treatment. The Company’s health care services referred to as care coordination services include pharmacy services vascular cardiovascular and endovascular specialty services non-dialysis laboratory testing services physician services hospitalist and intensivist services health plan services and urgent care services. The Company also offers a range of dialysis drugs.